• Jean Bernard, Charles-Hervé Vacheron, Nicolas Vantard, Emmanuel Bachy, Jean Christophe Richard, Frédéric Aubrun, Martin Cour, Anne Claire Lukaszewicz, Julien Bohe, Bernard Allaouchiche, Arnaud Friggeri, and Florent Wallet.
• Service de Médecine Intensive Réanimation Anesthésie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
• J Crit Care. 2023 Dec 1; 78: 154399154399.

PurposeThis study aimed to assess the outcome and factors associated with mortality in patients who received urgent chemotherapy (CT) in the intensive care unit (ICU) in Lyon, France.Material And MethodsA total of 147 adult patients diagnosed with cancer and requiring urgent CT during ICU stay between October 2014 and December 2019 were included in this retrospective study.ResultsHematological cancer was found in 77% of patients, and acute respiratory failure was the leading cause of ICU admission (46.3%). The 6-month mortality rate was 69.4%; patients with solid cancer had a higher risk of mortality. Patients who died within 6 months had a poor performance score and a higher SOFA score at admission. The multivariate analysis showed that solid tumors, sepsis on the day of CT, and SOFA score on the day of CT were associated with 6-month mortality. Additionally, 95% of patients who survived the ICU resumed conventional CT, with a higher likelihood of resuming CT among those with hematological cancer.ConclusionUrgent CT in the ICU is feasible in a specific subset of patients, mainly those with hematological cancer, with resumption of the curative treatment regimen after ICU discharge.Copyright © 2023 Elsevier Inc. All rights reserved.

12 keywords...

hide…